Type 2 Diabetes

Rob Danoff, DO, of Aria Health System, explains what should be done to reduce health management costs, while improving care of diabetic patients.

In this Q&A, experts discuss how emerging treatments and technologies are affecting diabetes costs.

Humana is using past evidence to reach patients at risk for diabetes.

As 2016 gets underway, improvements in diabetes health management are expected to progress. Here are some of the noteworthy trends to watch.

While diabetes, particularly type 2, remains an epidemic, the number of new diagnoses has begun to slow. Here are some developments contributing to the decrease.

Broader exchange of ideas for diabetes health management and related programs may result in more efficient community-based programs with a wider impact.

Several studies have demonstrated that telemedicine programs of different types can yield the same or better results than more traditional diabetes interventions.

The results of a large study of the impact of empagliflozin (Jardiance) on cardiovascular outcomes were recently published. Here are some key takeaways.

An important question is whether improvements in technology can make better control accessible to patients who are not currently good candidates for insulin pumps.

For patients with diabetes or high blood cholesterol, greater medication adherence is associated with a greater likelihood that the patient will achieve target biometric A1c and low-density lipoprotein levels, respectively, according to a poster session presented at the Academy of Managed Care Pharmacy meeting.

During their session at the AMPC conference in Orlando, presenters identified several diabetes management approaches that are improving medication adherence.

Partner with community-based organizations to implement quality diabetes programs for the Hispanic population.

Further research may determine whether changing sedentary behavior will reduce long-term outcomes.

Canadian study shows certain ethnic groups face higher heart disease risk factors than they did a decade ago.

A medical group in New York is rapidly shifting toward “value-based” care from fee-for-service (FFS)-spurred on by a program to reduce variations in physician practice that began by focusing on patients with diabetes.

Spending on healthcare can be good, but in the case of diabetes, more spending likely means worsening outcomes.

Diabetes costs $322 billion per year in the U.S. Help empower consumers for a healthier bottom line.

Payers and providers alike cite benefits from utilizing telemedicine as a strategy for diabetes care management. Here are two success stories.

Patients to assist insurer, association in creating program to ensure its relevancy and practicality for those with diabetes.

As the number of people with diabetes in the U.S. continues to climb, plans and integrated health systems are employing personalized strategies to help manage the disease.

If we can accurately understand each patient’s risk for disease, we can create more nuanced preventive care plans and better invest our resources.

In this blog, the vice president of medical affairs for Quest Diagnostics discusses how Medicaid expansion has impacted diabetes diagnoses.

A new health rankings report indicates in which states health plans and health executives encounter the most challenges when caring for seniors.

Consensus is building on the promise of genetic testing and other technological advances to help individualize testing, prevention and treatment for better outcomes.

People in states that expanded Medicaid under the Affordable Care Act are far more likely to be newly identified with diabetes than in non-expansion states, according to a study published online in Diabetes Care.